Pandion Therapeutics sought $58 million Series A funding to advance drug programs for autoimmune and inflammatory diseases Read more
Kite and Pfizer extend Clinical Trial collaboration to assess Yescarta in large B-cell lymphoma Read more
Relmada Therapeutics obtained global rights to market dextromethadone for treating CNS diseases Read more
Eiger Biopharmaceuticals disappointed over negative results of Phase 2 LIBERTY study in PAH Read more
Marina Biotech enters into agreement with Autotelic Bio for developing Marina’s IT-103 Clinical program Read more